Frans Hj Claas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Frans Hj Claas has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
J J Van Rood
13 shared publicationsG G Persijn
5 shared publications- Ilias I. N. Doxiadis
Leiden University Medical Center, Immunohematology and Blood Transfusion/ETRL, Leiden, Netherlands
5 shared publications E Goulmy
3 shared publicationsG M Schreuder
3 shared publicationsJ D'Amaro
3 shared publications
Latest Publications
- 1 October 2014
- Published by Elsevier in Transplant Immunology
- Vol. 31 (4) , 250
The PROCARE consortium: Towards an improved allocation strategy for kidney allografts
- 1 October 2014
- Published by Elsevier in Transplant Immunology
- Vol. 31 (4) , 250
The PROCARE consortium: Towards an improved allocation strategy for kidney allografts
- 1 June 2013
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 98 (1-2) , 29-38
Preservation of human placenta facilitates multicenter studies on the local immune response in normal and aberrant pregnancies
- 1 June 2013
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 98 (1-2) , 29-38
Preservation of human placenta facilitates multicenter studies on the local immune response in normal and aberrant pregnancies
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 792
A Novel ELISPOT Assay to Quantify HLA-Specific B Cells in HLA-Immunized Individuals
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 792
A Novel ELISPOT Assay to Quantify HLA-Specific B Cells in HLA-Immunized Individuals
- 1 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 1075
Renal Transplantation in the Presence of Anti-HLA Antibodies
- 1 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 1075
Renal Transplantation in the Presence of Anti-HLA Antibodies
- 1 November 2009
- Published by Elsevier in Human Immunology
- Vol. 70, S157-92
26-OR: Bortezomib affects the function of human B cells: Possible implications for desensitization protocols
- 1 November 2009
- Published by Elsevier in Human Immunology
- Vol. 70, S157-92
26-OR: Bortezomib affects the function of human B cells: Possible implications for desensitization protocols
- 13 August 2009
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 81 (2) , 124
MHC mediated immunoregulation at the fetal–maternal interface
- 13 August 2009
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 81 (2) , 124
MHC mediated immunoregulation at the fetal–maternal interface
- 1 June 2009
- Published by Elsevier in Transplantation Proceedings
- Vol. 41 (5) , 1577-1582
A Multiplex Bead Array Analysis to Monitor Donor-Specific Cytokine Responses After Withdrawal of Immunosuppression in HLA-Identical living Related Kidney Transplant Patients
- 1 June 2009
- Published by Elsevier in Transplantation Proceedings
- Vol. 41 (5) , 1577-1582
A Multiplex Bead Array Analysis to Monitor Donor-Specific Cytokine Responses After Withdrawal of Immunosuppression in HLA-Identical living Related Kidney Transplant Patients
- 1 June 2001
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 8 (3) , 315-317
Modulation of the alloimmune response by blood transfusions
- 1 June 2001
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 8 (3) , 315-317
Modulation of the alloimmune response by blood transfusions
- 1 December 2000
- Published by Wiley in Transfusion Medicine
- Vol. 10 (4) , 332
Frequency determination of RhD specific B-lymphocytes in RhD antagonism
- 1 December 2000
- Published by Wiley in Transfusion Medicine
- Vol. 10 (4) , 332
Frequency determination of RhD specific B-lymphocytes in RhD antagonism
- 15 July 2000
- Vol. 70 (1) , 157-61
Cross-reactive group matching does not lead to a better allocation and survival of donor kidneys.
In cadaveric renal transplantation HLA-A, -B, -DR matching of donor and recipient is beneficial for graft survival. However, allocation based on HLA matching seems to favor recipients with more frequently occurring HLA antigens. In this study we investigated whether matching on the basis of cross-reactive groups (CREGs), defined according to the United Network for Organ Sharing (UNOS), would be a good alternative for the allocation of kidneys without negatively influencing graft survival. Theoretically, this approach would provide more recipients with an immunologically well-matched donor organ. The influence of CREG matching on graft survival was studied in univariate analyses using the Eurotransplant database. No beneficial effect of CREG matching was observed, whereas a significant HLA matching effect was observed in the 0 CREG mismatched donor/ recipient combinations. Only in the small subgroup with 1 MM for HLA-A, -B and 0 MM for HLA-DR, a significantly better survival was observed, when this mismatch belonged to the 0 or 1 MM CREG group versus two or more MM CREG group. However, this subgroup concerns only 8% of the transplants performed. In contrast to other reports, our study showed that HLA matching is by far more beneficial than CREG matching. In the homogenous Eurotransplant population, adjusting the matching criteria toward CREG matching would not lead to an improved graft survival.
- 15 July 2000
- Vol. 70 (1) , 157-61
Cross-reactive group matching does not lead to a better allocation and survival of donor kidneys.
In cadaveric renal transplantation HLA-A, -B, -DR matching of donor and recipient is beneficial for graft survival. However, allocation based on HLA matching seems to favor recipients with more frequently occurring HLA antigens. In this study we investigated whether matching on the basis of cross-reactive groups (CREGs), defined according to the United Network for Organ Sharing (UNOS), would be a good alternative for the allocation of kidneys without negatively influencing graft survival. Theoretically, this approach would provide more recipients with an immunologically well-matched donor organ. The influence of CREG matching on graft survival was studied in univariate analyses using the Eurotransplant database. No beneficial effect of CREG matching was observed, whereas a significant HLA matching effect was observed in the 0 CREG mismatched donor/ recipient combinations. Only in the small subgroup with 1 MM for HLA-A, -B and 0 MM for HLA-DR, a significantly better survival was observed, when this mismatch belonged to the 0 or 1 MM CREG group versus two or more MM CREG group. However, this subgroup concerns only 8% of the transplants performed. In contrast to other reports, our study showed that HLA matching is by far more beneficial than CREG matching. In the homogenous Eurotransplant population, adjusting the matching criteria toward CREG matching would not lead to an improved graft survival.